Gavin Molinelli

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.

Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis.